Point-Counterpoint: Cascade reporting—useful tool to support antimicrobial stewardship, or dangerously misleading
Journal of Clinical Microbiology · 09.07.2025 · 63 (7)
DOI: 10.1128/jcm.01708-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, erschienen am 09.07.2025. Verfasst von Joseph L Kuti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Addressing antimicrobial resistance requires multi-disciplinary action, including from the clinical laboratory. Cascade reporting of the antimicrobial susceptibility test (AST) is a strategy used by some laboratories to nudge clinicians toward the use of more narrow-spectrum antimicrobials. Cascade reporting involves suppression of broader-spectrum antimicrobials if the narrower-spectrum first-line antimicrobials show in-vitro susceptibility. Studies have shown that cascade reporting can reduce use of broad-spectrum antimicrobials and reduce antimicrobial resistance rates. However, implementing cascade reporting can be complex, and some question the effectiveness on impacting long-term prescribing behaviors. Furthermore, there are concerns surrounding compliance and the possible negative impact on public health surveillance for antimicrobial resistance. In this article, experts weigh in on the benefits and risks associated with implementing AST cascade reporting. General consensus is that cascade reporting is a benefit to antimicrobial stewardship, but protocols need careful implementation to minimize risk to patients and public health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Department of Pathology, Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- LabCorp, Seattle, Washington, USA.
- Department of Practice, Sciences, and Health-Outcomes Research, University of Maryland Baltimore School of Pharmacy, Baltimore, Maryland, USA.
ORCID-Profile: Joseph L Kuti, Joseph D Lutgring, Patricia J Simner, Samia N Naccache, Emily L Heil
Zitieren
APA
Kuti, J. L., Lutgring, J. D., Simner, P. J., Naccache, S. N., & Heil, E. L. (2025). Point-Counterpoint: Cascade reporting—useful tool to support antimicrobial stewardship, or dangerously misleading. Journal of Clinical Microbiology, 63(7). https://doi.org/10.1128/jcm.01708-24
Vancouver
Kuti JL, Lutgring JD, Simner PJ, Naccache SN, Heil EL. Point-Counterpoint: Cascade reporting—useful tool to support antimicrobial stewardship, or dangerously misleading. Journal of Clinical Microbiology. 2025;63(7). doi:10.1128/jcm.01708-24
BibTeX
@article{Kuti2025,
author = {Kuti, Joseph L and Lutgring, Joseph D and Simner, Patricia J and Naccache, Samia N and Heil, Emily L},
title = {Point-Counterpoint: Cascade reporting—useful tool to support antimicrobial stewardship, or dangerously misleading},
journal = {Journal of Clinical Microbiology},
year = {2025},
volume = {63},
number = {7},
doi = {10.1128/jcm.01708-24}
}
EUVIMED